MAM
GSK icon

Mastrapasqua Asset Management’s GSK GSK Stock Holding History

Mastrapasqua Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,558
Closed -$637K – 142
2017
Q3 		$637K Sell
12,558
-234
-2% -$11.9K 0.13% 116
2017
Q2 		$689K Buy
12,792
+1,696
+15% +$90.4K 0.15% 114
2017
Q1 		$585K Buy
11,096
+2,580
+30% +$131K 0.13% 122
2016
Q4 		$410K Buy
8,516
+92
+1% +$4.54K 0.1% 122
2016
Q3 		$454K Buy
8,424
+488
+6% +$26.8K 0.11% 117
2016
Q2 		$430K Buy
7,936
+536
+7% +$28.2K 0.11% 117
2016
Q1 		$375K Buy
7,400
+222
+3% +$11.1K 0.09% 119
2015
Q4 		$362K Buy
+7,178
New +$366K 0.09% 122

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mastrapasqua Asset Management's GSK Position: Q4 2017 in Review

Mastrapasqua Asset Management sold out of GSK (GSK) in Q4 2017, closing a stake of 12,558 shares — an estimated $637K sold.

Mastrapasqua Asset Management first reported a position in GSK in Q4 2015 and held it in 8 quarters. The position peaked at $689K in Q2 2017. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

  • Mastrapasqua Asset Management reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
  • Mastrapasqua Asset Management sold 12,558 GSK shares in Q4 2017, an estimated $637K.
  • Mastrapasqua Asset Management first reported a position in GSK in Q4 2015 and held it in 8 quarters.
  • Mastrapasqua Asset Management's GSK position peaked at $689K in Q2 2017.
  • 763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on Mastrapasqua Asset Management's 13F filing for Q4 2017, filed 9 Feb 2018.